ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
Dow Jones
41.938,45
-1,63%
Euro vs US Dollar
1,02545
-0,01%
Bitcoin
94.332,27
-0,40%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Personalis Inc (PSNL) Börsenkurse

Personalis Inc

Personalis Inc (PSNL)

Persimmon PLC
Persimmon PLC
Persimmon PLC
5,59
-0,01
(-0,18%)
Geschlossen 11 Januar 10:00PM
Verzögert um 15 Minuten
5,59
0,00
(0,00%)
Nach Börsenschluss: 1:57AM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
5,59
Gebot
5,51
Fragen
5,70
Volumen
1.095.374
5,28 Tagesbereich 5,645
1,12 52-Wochen-Bereich 7,20
Marktkapitalisierung
394,923M
Handelsende
5,60
Handelsbeginn
5,56
Letzte Trade
1
@
5.46
Letzter Handelszeitpunkt
Finanzvolumen
US$ 5.970.259
VWAP
5,4504
Durchschnittliches Volumen (3 Mio.)
997.302
Ausgegebene Aktien
70.648.084
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,65
Gewinn pro Aktie (EPS)
-1,53
Erlöse
73,48M
Nettogewinn
-108,3M

Über Personalis Inc

Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT... Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions. Mehr anzeigen

Sektor
Medical Laboratories
Branche
Medical Laboratories
Website
www.personalis.com
Hauptsitz
Dover, Delaware, USA
Gegründet
-
Personalis Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker PSNL. The last closing price for Personalis was US$5,60. Over the last year, Personalis shares have traded in a share price range of US$ 1,12 to US$ 7,20.

Personalis currently has 70.648.084 shares in issue. The market capitalisation of Personalis is US$395,63 million. Personalis has a price to earnings ratio (PE ratio) of -3.65.

PSNL Neueste Nachrichten

Weitere Nachrichten

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

11 Stunden vor
Edgar (US Regulatory)

Form 8-K - Current report

07 Januar 2025
Edgar (US Regulatory)

Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue

Full year revenue of ~$84.6 million represents a 15% year-over-year increase Cash balance of ~$185.0 million expected to provide runway to cash flow break-even Personalis, Inc. (Nasdaq: PSNL), a...

07 Januar 2025
Business Wire

Form 8-K - Current report

27 Dezember 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

27 Dezember 2024
Edgar (US Regulatory)

Form 8-K - Current report

19 Dezember 2024
Edgar (US Regulatory)

Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna

Personalis, Inc. (NASDAQ: PSNL) announced today agreements with long time collaborators Merck and Moderna that accelerate the advancement of the company’s business strategy. The company has...

19 Dezember 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

18 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 Dezember 2024
Edgar (US Regulatory)

Personalis and Tempus Expand Collaboration to Biopharma

Expanded collaboration to yield greater biopharma access to Personalis’ MRD solution Personalis, Inc. (Nasdaq: PSNL) and Tempus AI, Inc. (Nasdaq: TEM) announced today that the companies have...

16 Dezember 2024
Business Wire
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.73-11.55063291146.326.985.2210627476.05198419CS
42.1261.09510086463.477.193.3616361015.54066369CS
120.919.18976545844.697.193.289973024.96729006CS
264.05262.9870129871.547.21.4912168004.65473736CS
523.47163.6792452832.127.21.127774993.99166559CS
156-7.15-56.122448979612.7413.440.89065553523.89608841CS
260-5.34-48.856358645910.9353.460.890656572912.19912928CS

PSNL - Frequently Asked Questions (FAQ)

What is the current Personalis share price?
The current share price of Personalis is US$ 5,59
How many Personalis shares are in issue?
Personalis has 70.648.084 shares in issue
What is the market cap of Personalis?
The market capitalisation of Personalis is USD 395,63M
What is the 1 year trading range for Personalis share price?
Personalis has traded in the range of US$ 1,12 to US$ 7,20 during the past year
What is the PE ratio of Personalis?
The price to earnings ratio of Personalis is -3,65
What is the cash to sales ratio of Personalis?
The cash to sales ratio of Personalis is 5,37
What is the reporting currency for Personalis?
Personalis reports financial results in USD
What is the latest annual turnover for Personalis?
The latest annual turnover of Personalis is USD 73,48M
What is the latest annual profit for Personalis?
The latest annual profit of Personalis is USD -108,3M
What is the registered address of Personalis?
The registered address for Personalis is 3500 SOUTH DUPONT HIGHWAY, DOVER, DELAWARE, 19901
What is the Personalis website address?
The website address for Personalis is www.personalis.com
Which industry sector does Personalis operate in?
Personalis operates in the MEDICAL LABORATORIES sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
VRMEVerifyMe Inc
US$ 2,57
(52,98%)
57,83M
WKEYWISeKey International Holdings AG
US$ 10,041
(52,83%)
6,72M
DATSDatChat Inc
US$ 4,8105
(49,86%)
158,65M
CDTConduit Pharmaceuticals Inc
US$ 0,1214
(48,05%)
1,17B
INTZIntrusion Inc
US$ 2,8888
(44,44%)
40,61M
IGMSIGM Biosciences Inc
US$ 2,095
(-66,21%)
5,69M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1,87
(-51,30%)
2,28M
MODVModivCare Inc
US$ 6,51
(-47,88%)
2,73M
AIFUAIX Inc
US$ 0,420501
(-47,76%)
7,83M
MRSNMersana Therapeutics Inc
US$ 0,691
(-46,85%)
58,31M
CDTConduit Pharmaceuticals Inc
US$ 0,1214
(48,05%)
1,17B
NVDANVIDIA Corporation
US$ 135,91
(-3,00%)
207,53M
RGTIRigetti Computing Inc
US$ 8,9299
(-11,06%)
178,82M
VMARVision Marine Technologies Inc
US$ 2,14
(40,79%)
175,57M
DATSDatChat Inc
US$ 4,8105
(49,86%)
158,65M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
PSNL
Personalis
BIT
INDI
ETF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten